Press Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral...
News
Drug resistance biomarker could improve cancer treatmentDrug resistance biomarker could improve cancer treatment
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key...
Production & Manufacturing
Impax, Perrigo to jointly develop topical generic drug
Impax Laboratories and Perrigo Company have signed a deal to develop and manufacture an undisclosed topical generic drug. The...
IT & Data Management
Systech secures $7.5m finance for software products expansion
Pharma serialization solutions provider Systech International has secured $7.5m as a venture loan from Horizon Technology Finance. The company...
Press Releases
PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence & Business in the Fast Developing Region
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened...
News
Discovery of molecular pathway of Alzheimer’s disease reveals new drug targets
The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets...
Drug Research
Paladin introduces grass pollen allergy medication in Canada
Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet, Oralair, against grass pollen allergies in Canada. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read